UnitedHealth Group investors provided what looked like grudging support this week for a pay package that could deliver more than $60 million over three years to returning CEO Stephen Hemsley.
Hemsley, who was named chief executive last month, will receive $1 million per year in salary plus a one-time grant of $60 million in stock options, provided he works as CEO for three years, securities filings say.
Shareholders registered just 60% support for the compensation arrangement during a non-binding advisory vote that concluded Monday during UnitedHealth’s annual meeting, according to figures released Wednesday by the Eden Prairie-based company.
That’s a slimmer approval margin than investors provided during all other advisory “say-on-pay” votes held by the company since 2020, according to a Minnesota Star Tribune review of regulatory filings.
Before this week’s tally, the weakest recent show of support came in 2021, when about 73% of shares were voted in support of the company’s executive pay packages. In 2020 and then again each year between 2022 and 2024, about 95% of shares backed executive compensation at the company.
Last month, advisory firm Glass Lewis recommended investors support the pay package. Institutional Shareholder Services, however, advised voting against Hemsley’s pay because the “sizeable front-loaded award ... lacks performance conditions,” the group said in a report last month. The firms’ reports are often closely watched by investors.
UnitedHealth Group defended the compensation arrangement, saying it is “overwhelmingly performance-based, with most of the value materializing only if the stock price increases.”
The $60 million in stock-based pay was chosen because it represents the median among comparable CEO compensation packages at similar companies — “in other words, three times $20 million, for the $60 million one-time award,“ board member Tim Flynn said Monday during the company’s annual meeting.